Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company (DBD.VN) Stock
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company

Company profile
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock reported revenue of 1.87 trillion VND for fiscal year 2025, up 8.0% from fiscal year 2024, and net income of 251.02 billion VND. That is a net profit margin of 13.5% for fiscal year 2025. In Q2 2026 (the quarter ended June 30, 2026) revenue was 471.67 billion VND, down 0.6% from a year before. In Q2 2026 it reported net income of 89.17 billion VND, against net income of 90.34 billion VND a year earlier. Our analysis of its filings shows revenue growing from 1.65 trillion VND in fiscal year 2023 to 1.87 trillion VND in fiscal year 2025, 6.3% a year on average. Binh Dinh Pharmaceutical and Medical Equipment Joint Stock reports about 1,498 full-time employees.
What stands out
- Revenue and net income in fiscal year 2025 were the highest of the last 5 fiscal years.
Figures from company filings; latest fiscal year ended December 31, 2025.
About Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company manufactures and trades in pharmaceuticals and medical equipment in Vietnam. It offers antibiotics; anticancer drugs; hemodialysis solutions; hepatobiliary drugs; analgesic and antipyretic drugs; drugs for muscles, bones, and joints; antihistamine anti-allergy drugs; ear, eye, nose, and throat drops; cardiovascular drugs; nervous system drugs; vitamins and minerals; endocrine hormones; respiratory drugs; antifungal and antiviral drugs; dermatologic drugs; antidotes; and drugs for treating lipid disorders. The company also provides automatic herbal medicine brewing stoves, distilled water tanks, hand sanitizers, medical solid waste incinerators, water distillers, washing machines, eye drop bottle washing machines, clothes dryers, autoclave machines, and drying and microclimate cabinets. In addition, it engages in the wholesale and retail sale of medicines, medicinal herbs, and medical equipment; and production of medicines, and medical chemicals and herbs. The company was founded in 1976 and is based in Quy Nhon, Vietnam.
Leadership
- Huong Thi Thanh Pham — CEO, GM, Director & Member of Executive Board, 60
- Phuong Huy Do — Chief Accountant, 43
- Dung Ngoc Nguyen — Deputy GM of Sales, Director & Member of Executive Board, 56
- Quynh Ngoc Thi Banh — Deputy GM of Production & Member of Executive Board, 56
- Linh Thi My Huynh — Company Secretary & Corporate Governance Officer, 25
How much revenue does Binh Dinh Pharmaceutical and Medical Equipment Joint Stock make?
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock reported 1.87 trillion VND in revenue for fiscal year 2025, up 8.0% from 1.73 trillion VND in fiscal year 2024. In Q2 2026 revenue was 471.67 billion VND.
What companies are similar to Binh Dinh Pharmaceutical and Medical Equipment Joint Stock?
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include DHG Pharmaceutical Joint Stock Company (DHG.VN), Cuu Long Pharmaceutical Joint Stock Company (DCL.VN), F.i.t Group Joint Stock Company (FIT.VN).
How has Binh Dinh Pharmaceutical and Medical Equipment Joint Stock's revenue changed over the last 5 fiscal years?
Revenue by fiscal year: FY2021, 1.56 trillion VND; FY2022, 1.55 trillion VND; FY2023, 1.65 trillion VND; FY2024, 1.73 trillion VND; FY2025, 1.87 trillion VND.
Company Information
Data as of .
How to cite: DataPorium, “Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company (DBD.VN)”, data as of Jun 30, 2026, https://dataporium.tech/stocks/DBD.VN